Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease

Overview of attention for article published in Alzheimer's Research & Therapy, March 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

news: 2 news outlets

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 103 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

News story from EurActiv on Thursday 13 July 2023

EurActiv, 13 Jul 2023

Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer's disease.

Alzforum, 25 Mar 2017

. Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer's disease.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.